Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
Amphotropic murine leukemia virus (MLV) replicates in cells from various mammalian species including humans and is a potential contaminant in MLV vector preparations for human gene transfer studies. Because MLV replication proceeds through an RNA genome that is generated under the control of viral enhancer and promoter elements, vectors were developed that delete such elements during transduction to reduce the generation of replication-competent virus. It was shown recently that replication of amphotropic MLV in certain human cells is possible without the 75 bp transcription enhancers. It is now demonstrated that enhancer-independent replication requires functional elements within U3 and is repressed by an extended deletion in the U3 region comprising enhancers, promoter and flanking sequences. It is concluded that the transcriptional inactivation of amphotropic MLV in human cells requires the combined deletion of enhancers and of additional elements in U3.
Ploss
Martin
M
Deutsches Krebsforschungszentrum (DKFZ), Angewandte Tumorvirologie F0400, Heidelberg, Germany.
Berdel
Bianca
B
Heber
Ricarda
R
Reuss
Frank U
FU
D000818:Animals; D001483:Base Sequence; D004742:Enhancer Elements, Genetic; D017353:Gene Deletion; D015967:Gene Expression Regulation, Viral; D006801:Humans; D009052:Leukemia Virus, Murine / Q000235:genetics / Q000502:physiology*; D051379:Mice; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured; D014779:Virus Replication